HR. 5160Reported

Stem Cell Therapeutic and Research Reauthorization Act of 2025

Chamber
House
Sponsor
Christopher H. SmithChristopher H. SmithHouse • District 4
Introduced
2025-09-04
Impact Score
48
Limited
Momentum
54
Active
Summary
Reauthorizes stem cell therapeutic and research programs through an amended measure ordered reported by committee
What this does
  • Extend stem cell research programs
Latest action
2026-05-21 — Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Full Text (PDF)Amendments
View on Congress.gov